Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in Heart

Retrieve available abstracts of 139 articles:
HTML format

Single Articles

    July 2022
  1. PARALE C, Velayutham R, Anantharaj A
    Tachycardia in a young man: does pulse oximetry give a clue?
    Heart. 2022;108:1266-1330.

  2. NGUYEN BO, Weberndorfer V, Crijns HJ, Geelhoed B, et al
    Prevalence and determinants of atrial fibrillation progression in paroxysmal atrial fibrillation.
    Heart. 2022 Jul 20. pii: heartjnl-2022-321027. doi: 10.1136/heartjnl-2022-321027
    PubMed     Abstract available

  3. VILALTA V, Cediel G, Mohammadi S, Lopez H, et al
    New-onset persistent left bundle branch block following sutureless aortic valve replacement.
    Heart. 2022 Jul 16. pii: heartjnl-2022-321191. doi: 10.1136/heartjnl-2022-321191
    PubMed     Abstract available

  4. KANY S, Cardoso VR, Bravo L, Williams JA, et al
    Eligibility for early rhythm control in patients with atrial fibrillation in the UK Biobank.
    Heart. 2022 Jul 14. pii: heartjnl-2022-321196. doi: 10.1136/heartjnl-2022-321196
    PubMed     Abstract available

  5. KIM HJ, Chang DH, Kim SO, Kim JK, et al
    Left atrial appendage preservation versus closure during surgical ablation of atrial fibrillation.
    Heart. 2022 Jul 13. pii: heartjnl-2022-320939. doi: 10.1136/heartjnl-2022-320939
    PubMed     Abstract available

    June 2022
  6. MARROQUIN L, Tirado-Conte G, Pracon R, Streb W, et al
    Management and outcomes of patients with left atrial appendage thrombus prior to percutaneous closure.
    Heart. 2022;108:1098-1106.
    PubMed     Abstract available

  7. AVILA P, Calvo D, Tamargo M, Uribarri A, et al
    Association of age with clinical features and ablation outcomes of paroxysmal supraventricular tachycardias.
    Heart. 2022;108:1107-1113.
    PubMed     Abstract available

  8. TAN HL, Remme CA
    Sudden cardiac death: recognising hidden risk among women versus men.
    Heart. 2022;108:992-993.

    May 2022
    Management of cardiac arrest in the cardiac catheterisation laboratory: guidelines tailored to place and occasion.
    Heart. 2022;108:907-908.

  10. OTTO CM
    Heartbeat: can cardiogenetics reduce adverse events due to catecholaminergic polymorphic ventricular tachycardia?
    Heart. 2022;108:816-818.

  11. POSTEMA PG, van der Werf C
    Catecholaminergic polymorphic ventricular tachycardia: differences in inheritance and implications for patients, families and future studies.
    Heart. 2022;108:820-821.

  12. SHIMAMOTO K, Ohno S, Kato K, Takayama K, et al
    Impact of cascade screening for catecholaminergic polymorphic ventricular tachycardia type 1.
    Heart. 2022;108:840-847.
    PubMed     Abstract available

  13. MARSMAN EMJ, Postema PG, Remme CA
    Brugada syndrome: update and future perspectives.
    Heart. 2022;108:668-675.
    PubMed     Abstract available

  14. HAYDOCK P, Camm AJ
    History and evolution of pacing and devices.
    Heart. 2022;108:794-799.
    PubMed     Abstract available

    April 2022
  15. ROSEBOOM E, Maass AH
    Inherited and modifiable factors need to be identified in young patients with atrioventricular block.
    Heart. 2022 Apr 5. pii: heartjnl-2022-320841. doi: 10.1136/heartjnl-2022-320841.

  16. KOMEN J, Pottegard A, Hjemdahl P, Mantel-Teeuwisse AK, et al
    Non-vitamin K antagonist oral anticoagulants, proton pump inhibitors and gastrointestinal bleeds.
    Heart. 2022;108:613-618.
    PubMed     Abstract available

  17. MORITA S, Malik AH, Kuno T, Ando T, et al
    Analysis of outcome of 6-month readmissions after percutaneous left atrial appendage occlusion.
    Heart. 2022;108:606-612.
    PubMed     Abstract available

  18. HOLT A, Blanche P, Zareini B, Rasmussen PV, et al
    Gastrointestinal bleeding risk following concomitant treatment with oral glucocorticoids in patients on non-vitamin K oral anticoagulants.
    Heart. 2022;108:626-632.
    PubMed     Abstract available

  19. HIGUCHI K, Bhargava M
    Management of premature ventricular complexes.
    Heart. 2022;108:565-572.

    March 2022
  20. PARK YJ, Park JW, Yu HT, Kim TH, et al
    Sex difference in atrial fibrillation recurrence after catheter ablation and antiarrhythmic drugs.
    Heart. 2022 Mar 24. pii: heartjnl-2021-320601. doi: 10.1136/heartjnl-2021-320601
    PubMed     Abstract available

  21. RAATIKAINEN P, Lassila R
    COVID-19: another reason for anticoagulation in patients with atrial fibrillation.
    Heart. 2022 Mar 21. pii: heartjnl-2022-320845. doi: 10.1136/heartjnl-2022-320845

  22. GILL S, Bunting KV, Sartini C, Cardoso VR, et al
    Smartphone detection of atrial fibrillation using photoplethysmography: a systematic review and meta-analysis.
    Heart. 2022 Mar 11. pii: heartjnl-2021-320417. doi: 10.1136/heartjnl-2021-320417
    PubMed     Abstract available

  23. HANDY A, Banerjee A, Wood AM, Dale C, et al
    Evaluation of antithrombotic use and COVID-19 outcomes in a nationwide atrial fibrillation cohort.
    Heart. 2022 Mar 10. pii: heartjnl-2021-320325. doi: 10.1136/heartjnl-2021-320325
    PubMed     Abstract available

  24. DYSSEKILDE JR, Christiansen MK, Johansen JB, Nielsen JC, et al
    Familial risk of atrioventricular block in first-degree relatives.
    Heart. 2022 Mar 4. pii: heartjnl-2021-320411. doi: 10.1136/heartjnl-2021-320411.
    PubMed     Abstract available

  25. FRANKE KB, Mahajan R
    Cardiac oxidative stress: a potential tool for risk stratification in cardiac sarcoidosis.
    Heart. 2022;108:410-411.

  26. YOSHITOMI R, Kobayashi S, Yano Y, Nakashima Y, et al
    Enhanced oxidative stress and presence of ventricular aneurysm for risk prediction in cardiac sarcoidosis.
    Heart. 2022;108:429-437.
    PubMed     Abstract available

    February 2022
  27. EVERS-DORPFELD S, Aeschbacher S, Hennings E, Eken C, et al
    Sex-specific differences in adverse outcome events among patients with atrial fibrillation.
    Heart. 2022 Feb 8. pii: heartjnl-2021-320122. doi: 10.1136/heartjnl-2021-320122.
    PubMed     Abstract available

  28. OTTO CM
    Heartbeat: bleeding risk in atrial fibrillation patients on non-vitamin K oral anticoagulant medications.
    Heart. 2022;108:243-245.

  29. GUPTA A, Arora GK, Isser HS
    An elderly woman with recurrent syncope.
    Heart. 2022;108:257-324.

  30. MORRONE D, De Caterina R
    Bleeding risk score: limits and practicability.
    Heart. 2022;108:246-248.

    January 2022
  31. TUTAREL O, Baris L, Budts W, Gamal Abd-El Aziz M, et al
    Pregnancy outcomes in women with a systemic right ventricle and transposition of the great arteries results from the ESC-EORP Registry of Pregnancy and Cardiac disease (ROPAC).
    Heart. 2022;108:117-123.
    PubMed     Abstract available

  32. VITALE G, Ditaranto R, Graziani F, Tanini I, et al
    Standard ECG for differential diagnosis between Anderson-Fabry disease and hypertrophic cardiomyopathy.
    Heart. 2022;108:54-60.
    PubMed     Abstract available

    December 2021
  33. OTTO CM
    Heartbeat: lower risk of dementia with a direct oral anticoagulatant, compared to a vitamin K antagonist, for patients with atrial fibrillation.
    Heart. 2021;107:1847-1849.

  34. DING WY, Mahida S
    Wide complex tachycardia: differentiating ventricular tachycardia from supraventricular tachycardia.
    Heart. 2021;107:1995-2003.

    November 2021
  35. OTTO CM
    Heartbeat: ECG approaches to early detection of atrial fibrillation.
    Heart. 2021;107:1765-1767.

    October 2021
  36. HIMELFARB JD, Shulman H, Olesovsky CJ, Rumman RK, et al
    Atrial fibrillation following transcatheter atrial septal defect closure: a systematic review and meta-analysis.
    Heart. 2021 Oct 21. pii: heartjnl-2021-319794. doi: 10.1136/heartjnl-2021-319794
    PubMed     Abstract available

  37. DEYELL MW, Hawkins NM
    Odd couple: premature ventricular contractions and heart failure.
    Heart. 2021 Oct 19. pii: heartjnl-2021-319986. doi: 10.1136/heartjnl-2021-319986

  38. CADOGAN SL, Powell E, Wing K, Wong AY, et al
    Anticoagulant prescribing for atrial fibrillation and risk of incident dementia.
    Heart. 2021 Oct 13. pii: heartjnl-2021-319672. doi: 10.1136/heartjnl-2021-319672
    PubMed     Abstract available

  39. CHUA W
    Clearing the cognitive cloud: direct oral anticoagulants or vitamin K antagonists for reducing dementia risk in patients with atrial fibrillation?
    Heart. 2021 Oct 13. pii: heartjnl-2021-320138. doi: 10.1136/heartjnl-2021-320138

  40. NADARAJAH R, Alsaeed E, Hurdus B, Aktaa S, et al
    Prediction of incident atrial fibrillation in community-based electronic health records: a systematic review with meta-analysis.
    Heart. 2021 Oct 4. pii: heartjnl-2021-320036. doi: 10.1136/heartjnl-2021-320036.
    PubMed     Abstract available

  41. ZAMAN J, Agarwal S
    Management of ventricular tachycardia storm.
    Heart. 2021;107:1671-1677.

    September 2021
  42. BARNETT-GRINESS O, Stein N, Kotler A, Saliba W, et al
    Novel bleeding prediction model in atrial fibrillation patients on new oral anticoagulants.
    Heart. 2021 Sep 21. pii: heartjnl-2021-319702. doi: 10.1136/heartjnl-2021-319702
    PubMed     Abstract available

  43. KASHOU A, Noseworthy P
    Predicting incident atrial fibrillation in sinus rhythm: more than just trusting the 'black box'.
    Heart. 2021 Sep 7. pii: heartjnl-2021-319385. doi: 10.1136/heartjnl-2021-319385.

  44. LIMPITIKUL WB, Dewland TA, Vittinghoff E, Soliman E, et al
    Premature ventricular complexes and development of heart failure in a community-based population.
    Heart. 2021 Sep 7. pii: heartjnl-2021-319473. doi: 10.1136/heartjnl-2021-319473.
    PubMed     Abstract available

  45. NASER JA, Pislaru S, Stan MN, Lin G, et al
    Incidence, risk factors, natural history and outcomes of heart failure in patients with Graves' disease.
    Heart. 2021 Sep 6. pii: heartjnl-2021-319752. doi: 10.1136/heartjnl-2021-319752.
    PubMed     Abstract available

    August 2021
  46. BLAAUW Y, Mulder B, Rienstra M
    Is catheter ablation of atrial fibrillation as first-line treatment ready for prime time?
    Heart. 2021 Aug 12. pii: heartjnl-2021-319832. doi: 10.1136/heartjnl-2021-319832

  47. KANY S, Schnabel R
    Adding to the evidence or to the confusion: dual antithrombotic therapy in chronic coronary syndrome and atrial fibrillation.
    Heart. 2021 Aug 12. pii: heartjnl-2021-319830. doi: 10.1136/heartjnl-2021-319830

  48. SCHNABEL RB, Wallenhorst C, Engler D, Blankenberg S, et al
    Refined atrial fibrillation screening and cost-effectiveness in the German population.
    Heart. 2021 Aug 10. pii: heartjnl-2020-318882. doi: 10.1136/heartjnl-2020-318882
    PubMed     Abstract available

  49. TOOLEY JE, Perez MV
    Role of digital health in detection and management of atrial fibrillation.
    Heart. 2021 Aug 3. pii: heartjnl-2020-318262. doi: 10.1136/heartjnl-2020-318262.
    PubMed     Abstract available

  50. OTTO CM
    Heartbeat: improved quality of life and reduced healthcare utilisation after catheter ablation in patients with drug-resistant paroxysmal atrial fibrillation.
    Heart. 2021;107:1271-1273.

    July 2021
  51. FUKAYA H, Ako J, Yasuda S, Kaikita K, et al
    Aspirin versus P2Y12 inhibitors with anticoagulation therapy for atrial fibrillation.
    Heart. 2021 Jul 14. pii: heartjnl-2021-319321. doi: 10.1136/heartjnl-2021-319321
    PubMed     Abstract available

  52. IMBERTI JF, Ding WY, Kotalczyk A, Zhang J, et al
    Catheter ablation as first-line treatment for paroxysmal atrial fibrillation: a systematic review and meta-analysis.
    Heart. 2021 Jul 14. pii: heartjnl-2021-319496. doi: 10.1136/heartjnl-2021-319496
    PubMed     Abstract available

  53. PHILLIPS K, Subramanian A, Thomas GN, Khan N, et al
    Trends in the pharmacological management of atrial fibrillation in UK general practice 2008-2018.
    Heart. 2021 Jul 5. pii: heartjnl-2021-319338. doi: 10.1136/heartjnl-2021-319338.
    PubMed     Abstract available

    June 2021
  54. CHEN TH, Chu YC, Ou SM, Tarng DC, et al
    Associations of atrial fibrillation with renal function decline in patients with chronic kidney disease.
    Heart. 2021 Jun 30. pii: heartjnl-2021-319297. doi: 10.1136/heartjnl-2021-319297
    PubMed     Abstract available

  55. MULDER BA, Rienstra M, Van Gelder IC, Blaauw Y, et al
    Update on management of atrial fibrillation in heart failure: a focus on ablation.
    Heart. 2021 Jun 4. pii: heartjnl-2020-318081. doi: 10.1136/heartjnl-2020-318081.
    PubMed     Abstract available

  56. SANZ-GARCIA A, Cecconi A, Vera A, Camarasaltas JM, et al
    Electrocardiographic biomarkers to predict atrial fibrillation in sinus rhythm electrocardiograms.
    Heart. 2021 Jun 4. pii: heartjnl-2021-319120. doi: 10.1136/heartjnl-2021-319120.
    PubMed     Abstract available

  57. MINNERS J, Jander N
    Consecutive, index and representative beats: obtaining reliable information despite an irregular heart rhythm.
    Heart. 2021;107:862-863.

  58. BRIGNOLE M, Rivasi G
    New insights in diagnostics and therapies in syncope: a novel approach to non-cardiac syncope.
    Heart. 2021;107:864-873.
    PubMed     Abstract available

  59. PARKER WA, Storey RF
    Antithrombotic therapy for patients with chronic coronary syndromes.
    Heart. 2021;107:925-933.

    May 2021
  60. WILDE AAM, Amin AS, Postema PG
    Diagnosis, management and therapeutic strategies for congenital long QT syndrome.
    Heart. 2021 May 26. pii: heartjnl-2020-318259. doi: 10.1136/heartjnl-2020-318259
    PubMed     Abstract available

  61. KAWAJI T, Ogawa H, Hamatani Y, Kato M, et al
    Association of inverted T wave during atrial fibrillation rhythm with subsequent cardiac events.
    Heart. 2021 May 26. pii: heartjnl-2021-319199. doi: 10.1136/heartjnl-2021-319199
    PubMed     Abstract available

  62. NICOLI CD, O'Neal WT, Levitan EB, Singleton MJ, et al
    Atrial fibrillation and risk of incident heart failure with reduced versus preserved ejection fraction.
    Heart. 2021 May 24. pii: heartjnl-2021-319122. doi: 10.1136/heartjnl-2021-319122
    PubMed     Abstract available

  63. ROSSIDES M, Kullberg S, Grunewald J, Eklund A, et al
    Risk and predictors of heart failure in sarcoidosis in a population-based cohort study from Sweden.
    Heart. 2021 May 21. pii: heartjnl-2021-319129. doi: 10.1136/heartjnl-2021-319129
    PubMed     Abstract available

  64. ELVAN A
    It's all about improvement of quality of life and reduction of disease burden in atrial fibrillation ablation.
    Heart. 2021 May 20. pii: heartjnl-2021-319382. doi: 10.1136/heartjnl-2021-319382

  65. BOSMAN LP, Te Riele ASJM
    Arrhythmogenic right ventricular cardiomyopathy: a focused update on diagnosis and risk stratification.
    Heart. 2021 May 14. pii: heartjnl-2021-319113. doi: 10.1136/heartjnl-2021-319113
    PubMed     Abstract available

  66. CHOI Y, Lee Y, Kim SH, Kim S, et al
    Single direct oral anticoagulant therapy in stable patients with atrial fibrillation beyond 1 year after coronary stent implantation.
    Heart. 2021 May 14. pii: heartjnl-2020-318750. doi: 10.1136/heartjnl-2020-318750
    PubMed     Abstract available

  67. GUPTA D, Ding WY
    Contemporary management of persistent atrial fibrillation.
    Heart. 2021 May 14. pii: heartjnl-2020-317422. doi: 10.1136/heartjnl-2020-317422

  68. CHUA W, Fabritz L
    Heart failure in patients with atrial fibrillation: why it matters now more than ever.
    Heart. 2021 May 13. pii: heartjnl-2021-319145. doi: 10.1136/heartjnl-2021-319145

  69. RUTHERFORD OW, Jonasson C, Ghanima W, Soderdahl F, et al
    Effectiveness and safety of oral anticoagulants in elderly patients with atrial fibrillation.
    Heart. 2021 May 11. pii: heartjnl-2020-318753. doi: 10.1136/heartjnl-2020-318753
    PubMed     Abstract available

  70. GUPTA D, Vijgen J, Potter T, Scherr D, et al
    Quality of life and healthcare utilisation improvements after atrial fibrillation ablation.
    Heart. 2021 May 5. pii: heartjnl-2020-318676. doi: 10.1136/heartjnl-2020-318676.
    PubMed     Abstract available

  71. JOLOBE O
    Next frontier is inclusion of high-grade carotid artery stenosis in the CHA2DS2 Vasc score.
    Heart. 2021;107:767.

    Stroke risk in rheumatic heart disease.
    Heart. 2021;107:694-696.

  73. FAN P, Zhang Y, Lu YT, Yang KQ, et al
    Prognostic value of plasma big endothelin-1 in left ventricular non-compaction cardiomyopathy.
    Heart. 2021;107:836-841.
    PubMed     Abstract available

    April 2021
  74. SANTOS IS, Bensenor IM
    Cardiovascular health and atrial fibrillation.
    Heart. 2021 Apr 15. pii: heartjnl-2021-319253. doi: 10.1136/heartjnl-2021-319253

  75. LEE JH, Yang PS, Yu HT, Kim TH, et al
    Association of cardiovascular health and incident atrial fibrillation in elderly population.
    Heart. 2021 Apr 2. pii: heartjnl-2020-318858. doi: 10.1136/heartjnl-2020-318858.
    PubMed     Abstract available

  76. YEO C, Wang Y, Tan VH
    Wide complex tachycardia captured on smartwatch.
    Heart. 2021;107:626-684.

  77. GEURINK K, Holmes D, Ezekowitz MD, Pieper K, et al
    Patterns of oral anticoagulation use with cardioversion in clinical practice.
    Heart. 2021;107:642-649.
    PubMed     Abstract available

  78. SPARROW R, Sanjoy S, Choi YH, Elgendy IY, et al
    Racial, ethnic and socioeconomic disparities in patients undergoing left atrial appendage closure.
    Heart. 2021 Apr 1. pii: heartjnl-2020-318650. doi: 10.1136/heartjnl-2020-318650.
    PubMed     Abstract available

    March 2021
  79. MELDUNI R, Nkomo VT, Wysokinski W, Gersh BJ, et al
    Risk of left atrial appendage thrombus and stroke in patients with atrial fibrillation and mitral regurgitation.
    Heart. 2021 Mar 25. pii: heartjnl-2020-317659. doi: 10.1136/heartjnl-2020-317659
    PubMed     Abstract available

  80. WEBER C, Hung J, Hickling S, Nedkoff L, et al
    Incidence, predictors and mortality risk of new heart failure in patients hospitalised with atrial fibrillation.
    Heart. 2021 Mar 11. pii: heartjnl-2020-318648. doi: 10.1136/heartjnl-2020-318648
    PubMed     Abstract available

  81. BUNTING KV, Gill SK, Sitch A, Mehta S, et al
    Improving the diagnosis of heart failure in patients with atrial fibrillation.
    Heart. 2021 Mar 10. pii: heartjnl-2020-318557. doi: 10.1136/heartjnl-2020-318557
    PubMed     Abstract available

  82. GUASCH E
    Natriuretic peptides in atrial fibrillation: evidence is here, but are we ready to go one step beyond?
    Heart. 2021 Mar 9. pii: heartjnl-2020-318335. doi: 10.1136/heartjnl-2020-318335.

  83. WOZNIAK O, Borowiec K, Konka M, Cicha-Mikolajczyk A, et al
    Implantable cardiac defibrillator events in patients with arrhythmogenic right ventricular cardiomyopathy.
    Heart. 2021 Mar 4. pii: heartjnl-2020-318415. doi: 10.1136/heartjnl-2020-318415.
    PubMed     Abstract available

    February 2021
  84. LOWRES N, Giskes K, Freedman B
    Next frontier in management of atrial fibrillation.
    Heart. 2021 Feb 23. pii: heartjnl-2021-318961. doi: 10.1136/heartjnl-2021-318961

    Biomarkers for detection of a thrombus in the left atrial appendage: the search for the grail?
    Heart. 2021;107:176-177.

    January 2021
  86. KORNEJ J, Benjamin EJ, Magnani JW
    Atrial fibrillation: global burdens and global opportunities.
    Heart. 2021 Jan 28. pii: heartjnl-2020-318480. doi: 10.1136/heartjnl-2020-318480

  87. DU X, Guo L, Xia S, Du J, et al
    Atrial fibrillation prevalence, awareness and management in a nationwide survey of adults in China.
    Heart. 2021 Jan 28. pii: heartjnl-2020-317915. doi: 10.1136/heartjnl-2020-317915
    PubMed     Abstract available

  88. PELLEGRINI CN, Buzkova P, Lichtenstein AH, Matthan NR, et al
    Individual non-esterified fatty acids and incident atrial fibrillation late in life.
    Heart. 2021 Jan 22. pii: heartjnl-2020-317929. doi: 10.1136/heartjnl-2020-317929
    PubMed     Abstract available

  89. PAK HN, Park JW, Yang SY, Kim M, et al
    Sex differences in mapping and rhythm outcomes of a repeat atrial fibrillation ablation.
    Heart. 2021 Jan 22. pii: heartjnl-2020-318282. doi: 10.1136/heartjnl-2020-318282
    PubMed     Abstract available

  90. OTTO CM
    Heartbeat: increased use of NOACs in patients with atrial fibrillation reduces health care system costs by reducing stroke incidence.
    Heart. 2021;107:1-3.

  91. SINGH T, Newby DE
    Is the fear of disease worse than the disease itself?
    Heart. 2021;107:91-92.

    December 2020
  92. LOWRES N, Giskes K, Freedman B
    Next frontier for stroke prevention in atrial fibrillation: ensuring anticoagulant persistence.
    Heart. 2020 Dec 23. pii: heartjnl-2020-318392. doi: 10.1136/heartjnl-2020-318392

  93. GARCIA RODRIGUEZ LA, Cea Soriano L, Munk Hald S, Hallas J, et al
    Discontinuation of oral anticoagulation in atrial fibrillation and risk of ischaemic stroke.
    Heart. 2020 Dec 11. pii: heartjnl-2020-317887. doi: 10.1136/heartjnl-2020-317887
    PubMed     Abstract available

  94. HANON O, Vidal JS, Pisica-Donose G, Orvoen G, et al
    Bleeding risk with rivaroxaban compared with vitamin K antagonists in patients aged 80 years or older with atrial fibrillation.
    Heart. 2020 Dec 1. pii: heartjnl-2020-317923. doi: 10.1136/heartjnl-2020-317923.
    PubMed     Abstract available

    November 2020
  95. CIPRIANI A, Bauce B
    Ventricular arrhythmias in mitral valve prolapse: new explanations for an old problem.
    Heart. 2020 Nov 25. pii: heartjnl-2020-318086. doi: 10.1136/heartjnl-2020-318086

  96. HAMATANI Y, Iguchi M, Ueno K, Aono Y, et al
    Prognostic significance of natriuretic peptide levels in atrial fibrillation without heart failure.
    Heart. 2020 Nov 20. pii: heartjnl-2020-317735. doi: 10.1136/heartjnl-2020-317735
    PubMed     Abstract available

  97. WANG L, Ze F, Li J, Mi L, et al
    Trends of global burden of atrial fibrillation/flutter from Global Burden of Disease Study 2017.
    Heart. 2020 Nov 4. pii: heartjnl-2020-317656. doi: 10.1136/heartjnl-2020-317656.
    PubMed     Abstract available

    October 2020
  98. ORLOWSKI A, Gale CP, Ashton R, Petrungaro B, et al
    Clinical and budget impacts of changes in oral anticoagulation prescribing for atrial fibrillation.
    Heart. 2020 Oct 28. pii: heartjnl-2020-317006. doi: 10.1136/heartjnl-2020-317006
    PubMed     Abstract available

  99. BARRA S, Providencia R
    Anticoagulation in atrial fibrillation.
    Heart. 2020 Oct 28. pii: heartjnl-2020-316728. doi: 10.1136/heartjnl-2020-316728

  100. BOYLE PM, Del Alamo JC, Akoum N
    Fibrosis, atrial fibrillation and stroke: clinical updates and emerging mechanistic models.
    Heart. 2020 Oct 23. pii: heartjnl-2020-317455. doi: 10.1136/heartjnl-2020-317455
    PubMed     Abstract available

  101. ALMORAD A, Ohanyan A, Pintea Bentea G, Wielandts JY, et al
    D-dimer blood concentrations to exclude left atrial thrombus in patients with atrial fibrillation.
    Heart. 2020 Oct 21. pii: heartjnl-2020-317612. doi: 10.1136/heartjnl-2020-317612
    PubMed     Abstract available

  102. MULDER BA, Rienstra M, Blaauw Y
    Evaluation and treatment of premature ventricular contractions in heart failure with reduced ejection fraction.
    Heart. 2020 Oct 19. pii: heartjnl-2020-317491. doi: 10.1136/heartjnl-2020-317491
    PubMed     Abstract available

  103. MIDDELDORP ME, Gupta A, Elliott A, Kadhim K, et al
    Cessation of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.
    Heart. 2020 Oct 16. pii: heartjnl-2020-317418. doi: 10.1136/heartjnl-2020-317418
    PubMed     Abstract available

  104. PICCINI JP, Todd DM, Massaro T, Lougee A, et al
    Changes in quality of life, cognition and functional status following catheter ablation of atrial fibrillation.
    Heart. 2020 Oct 12. pii: heartjnl-2020-316612. doi: 10.1136/heartjnl-2020-316612
    PubMed     Abstract available

  105. SRIDHAR AR, Colbert R
    Quality of life after atrial fibrillation ablation: measuring the most important end-point.
    Heart. 2020 Oct 12. pii: heartjnl-2020-317547. doi: 10.1136/heartjnl-2020-317547

  106. HECKMAN L, Vijayaraman P, Luermans J, Stipdonk AMW, et al
    Novel bradycardia pacing strategies.
    Heart. 2020 Oct 7. pii: heartjnl-2020-316849. doi: 10.1136/heartjnl-2020-316849.
    PubMed     Abstract available

    Atrial fibrillation in heart failure with preserved ejection fraction: a risk marker, risk factor or confounder?
    Heart. 2020 Oct 5. pii: heartjnl-2020-317978. doi: 10.1136/heartjnl-2020-317978.

  108. VAN WIJNGAARDEN AL, de Riva M, Hiemstra YL, van der Bijl P, et al
    Parameters associated with ventricular arrhythmias in mitral valve prolapse with significant regurgitation.
    Heart. 2020 Oct 1. pii: heartjnl-2020-317451. doi: 10.1136/heartjnl-2020-317451.
    PubMed     Abstract available

  109. PFIRMAN KS, Dawson Dowe J, Gaba D
    Man in his 70s with fatigue, dyspnoea and recurrent atrial fibrillation.
    Heart. 2020;106:1572-1619.

    September 2020
  110. CARNICELLI AP, Al-Khatib SM, Xavier D, Dalgaard F, et al
    Premature permanent discontinuation of apixaban or warfarin in patients with atrial fibrillation.
    Heart. 2020 Sep 16. pii: heartjnl-2020-317229. doi: 10.1136/heartjnl-2020-317229
    PubMed     Abstract available

  111. CHU G, Valerio L, van der Wall SJ, Barco S, et al
    Tailoring anticoagulant treatment of patients with atrial fibrillation using a novel bleeding risk score.
    Heart. 2020 Sep 9. pii: heartjnl-2019-316305. doi: 10.1136/heartjnl-2019-316305.
    PubMed     Abstract available

  112. IHSAN J, Khand A, Adlan AM
    Ventricular storm following late presentation acute myocardial infarction.
    Heart. 2020;106:1399-1448.

    August 2020
  113. KJERPESETH LJ, Igland J, Selmer R, Ellekjaer H, et al
    Prevalence and incidence rates of atrial fibrillation in Norway 2004-2014.
    Heart. 2020 Aug 20. pii: heartjnl-2020-316624. doi: 10.1136/heartjnl-2020-316624
    PubMed     Abstract available

  114. MAEDA T, Nishi T, Funakoshi S, Tada K, et al
    Residual risks of ischaemic stroke and systemic embolism among atrial fibrillation patients with anticoagulation: large-scale real-world data (F-CREATE project).
    Heart. 2020 Aug 14. pii: heartjnl-2020-317299. doi: 10.1136/heartjnl-2020-317299
    PubMed     Abstract available

  115. HENDRIKS J, Gallagher C, Nyfort-Hansen K, Lau D, et al
    Adherence to anticoagulation therapy in patients with atrial fibrillation: is a tailored team-based approach warranted?
    Heart. 2020 Aug 7. pii: heartjnl-2020-317478. doi: 10.1136/heartjnl-2020-317478.

    July 2020
  116. DING WY, Gupta D, Lip GYH
    Atrial fibrillation and the prothrombotic state: revisiting Virchow's triad in 2020.
    Heart. 2020 Jul 16. pii: heartjnl-2020-316977. doi: 10.1136/heartjnl-2020-316977
    PubMed     Abstract available

  117. LYCKHAGE LF, Hansen ML, Toft JC, Larsen SL, et al
    Continuous electrocardiography for detecting atrial fibrillation beyond 1 year after stroke in primary care.
    Heart. 2020 Jul 3. pii: heartjnl-2020-316904. doi: 10.1136/heartjnl-2020-316904.
    PubMed     Abstract available

    June 2020
  118. ROSANO G, Savarese G
    Inter-twinned relationship between heart failure and atrial fibrillation.
    Heart. 2020 Jun 1. pii: heartjnl-2020-316886. doi: 10.1136/heartjnl-2020-316886.

    May 2020
  119. AL SAID S, Katus HA, Alabed S
    Cochrane corner: NOACs in atrial fibrillation patients post-percutaneous coronary intervention.
    Heart. 2020 May 29. pii: heartjnl-2020-316726. doi: 10.1136/heartjnl-2020-316726

  120. WONG KC, Klimis H, Lowres N, von Huben A, et al
    Diagnostic accuracy of handheld electrocardiogram devices in detecting atrial fibrillation in adults in community versus hospital settings: a systematic review and meta-analysis.
    Heart. 2020 May 11. pii: heartjnl-2020-316611. doi: 10.1136/heartjnl-2020-316611
    PubMed     Abstract available

  121. KIM WK, Kim HJ, Kim JB, Jung SH, et al
    Exclusion versus preservation of the left atrial appendage in rheumatic mitral valve surgery.
    Heart. 2020 May 6. pii: heartjnl-2019-316387. doi: 10.1136/heartjnl-2019-316387.
    PubMed     Abstract available

  122. OTTO CM
    Heartbeat: smartwatch devices for detection of atrial fibrillation.
    Heart. 2020;106:627-628.

  123. SHAH RL, Badhwar N
    Approach to narrow complex tachycardia: non-invasive guide to interpretation and management.
    Heart. 2020;106:772-783.

    April 2020
  124. SON MK, Park JJ, Lim NK, Kim WH, et al
    Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction.
    Heart. 2020 Apr 27. pii: heartjnl-2019-316219. doi: 10.1136/heartjnl-2019-316219
    PubMed     Abstract available

  125. GASPARINI M, Kloppe A, Lunati M, Varma N, et al
    Sex differences in implantable cardiac defibrillator therapy according to arrhythmia detection times.
    Heart. 2020;106:520-526.
    PubMed     Abstract available

  126. THOMAS MR, Grove EL, Kirchhof P
    Complex antithrombotic combinations: how to find the perfect blend?
    Heart. 2020;106:557-558.

    March 2020
  127. KRISAI P, Blum S, Aeschbacher S, Beer JH, et al
    Associations of symptoms and quality of life with outcomes in patients with atrial fibrillation.
    Heart. 2020 Mar 31. pii: heartjnl-2019-316314. doi: 10.1136/heartjnl-2019-316314
    PubMed     Abstract available

  128. YAO X, Noseworthy P
    NOAC dosing and monitoring: really as simple as it seems?
    Heart. 2020;106:321-322.

    February 2020
  129. KIM JY, Kim SH, Myong JP, Choi Y, et al
    Ten-year trends in the incidence, treatment and outcomes of patients with mitral stenosis in Korea.
    Heart. 2020 Feb 6. pii: heartjnl-2019-315883. doi: 10.1136/heartjnl-2019-315883.
    PubMed     Abstract available

  130. BRUIKMAN C, de Ronde MWJ, Amin A, Levy S, et al
    Sudden cardiac death in families with premature cardiovascular disease.
    Heart. 2020;106:228-232.
    PubMed     Abstract available

  131. KAMAKURA T, Shinohara T, Yodogawa K, Murakoshi N, et al
    Long-term prognosis of patients withJ-wave syndrome.
    Heart. 2020;106:299-306.
    PubMed     Abstract available

    January 2020
  132. NELSON AJ, Patel MR
    Ischaemic stroke in heart failure: back to basics?
    Heart. 2020 Jan 27. pii: heartjnl-2019-315957. doi: 10.1136/heartjnl-2019-315957

  133. TAN TC, Nunes MCP, Handschumacher M, Pontes-Neto O, et al
    Left atrial cross-sectional area is a novel measure of atrial shape associated with cardioembolic strokes.
    Heart. 2020 Jan 24. pii: heartjnl-2019-315964. doi: 10.1136/heartjnl-2019-315964
    PubMed     Abstract available

  134. MUTLUER FO, Canpolat U, Yap SC
    Premature ventricular contraction-induced cardiomyopathy entails more than only systolic left ventricular dysfunction.
    Heart. 2020;106:164.

    December 2019
  135. UEBERHAM L, Konig S, Hohenstein S, Mueller-Roething R, et al
    Sex differences of resource utilisation and outcomes in patients with atrial arrhythmias and heart failure.
    Heart. 2019 Dec 19. pii: heartjnl-2019-315566. doi: 10.1136/heartjnl-2019-315566
    PubMed     Abstract available

    October 2019
  136. GOLDSWEIG A, Aronow HD
    Identifying patients likely to be readmitted after transcatheter aortic valve replacement.
    Heart. 2019 Oct 24. pii: heartjnl-2019-315381. doi: 10.1136/heartjnl-2019-315381
    PubMed     Abstract available

    May 2019
  137. INGRAHAM BS, Pislaru SV, Nkomo VT, Nishimura RA, et al
    Characteristics and treatment strategies for severe tricuspid regurgitation.
    Heart. 2019 May 15. pii: heartjnl-2019-314741. doi: 10.1136/heartjnl-2019-314741
    PubMed     Abstract available

    March 2019
  138. OTTO CM
    Heartbeat: Risk stratification for asymptomatic severe aortic stenosis.
    Heart. 2019;105:347-349.

    February 2019
  139. ERMAKOV S, Gulhar R, Lim L, Bibby D, et al
    Left ventricular mechanical dispersion predicts arrhythmic risk in mitral valve prolapse.
    Heart. 2019 Feb 12. pii: heartjnl-2018-314269. doi: 10.1136/heartjnl-2018-314269
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.